Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist that signals your brain to reduce hunger, slow stomach emptying, and improve blood sugar control—mechanisms that drive meaningful weight reduction in most patients. Research published in major medical journals documents average weight losses ranging from 10% to 22% of starting body weight, though your personal outcome depends on several individual factors. Understanding realistic expectations helps you set achievable goals and stay committed to treatment.
Clinical Trial Data on Semaglutide Weight Loss
The STEP trials, which evaluated semaglutide's safety and effectiveness, enrolled over 4,500 adults without diabetes who had obesity or weight-related conditions. Participants receiving 2.4 mg weekly semaglutide lost an average of 14.9% of their starting body weight over 68 weeks, compared to 2.4% in the placebo group. At the highest dose, some participants achieved losses exceeding 20% of their initial weight, though outcomes were highly individual.
Weight loss typically follows a pattern: most participants see initial reductions within the first 4-8 weeks as appetite suppression begins, followed by steady monthly losses through month 8-12. After that point, weight loss often plateaus as your body adapts, though maintaining the loss becomes the primary benefit. These timelines are not guaranteed and depend heavily on adherence, diet quality, physical activity, and your body's responsiveness to the medication.
Factors That Influence Your Individual Weight Loss Results
Your genetic makeup plays a significant role in how your body responds to semaglutide. Key genetic variants in the GLP1R gene (such as rs6923761) and the FTO gene (rs9939609) influence how effectively your appetite-control pathways respond to GLP-1 signaling. People with genetic predispositions toward higher appetite sensitivity may experience more pronounced appetite suppression, while others achieve results through improved metabolic efficiency.
Lifestyle choices amplify or limit medication effectiveness: consistent calorie reduction, protein intake, regular physical activity, and sleep quality all meaningfully impact your final weight loss. Starting dose also matters—many patients begin at lower doses (0.25 mg) and gradually increase to 2.4 mg over 4-12 weeks, with higher doses generally producing larger reductions. Your metabolism, baseline body composition, existing health conditions, and medication adherence create your unique weight loss trajectory.
Monthly Weight Loss Expectations During Treatment
Most patients report losing 1-2 pounds per week during the active weight loss phase (weeks 4-24), though this rate slows as treatment progresses. By month 3-4, weekly losses typically decrease to 0.5-1 pound, which represents sustainable, body-composition-preserving weight reduction. Some people experience rapid initial losses of 3-4 pounds in the first month due to reduced fluid retention and decreased food intake, while others show more gradual declines.
Plateaus are normal and expected—your body naturally adapts to medication and calorie restriction, requiring patience and consistency to continue progressing. Many patients benefit from adjusting exercise intensity, reassessing portion sizes, or working with a registered dietitian during plateau periods. The plateau phase typically marks transition from active weight loss to weight maintenance, which is equally important for long-term success.
Personalized Semaglutide Therapy at PlexusDx
PlexusDx offers compounded semaglutide injections starting at $149 per month, providing access to weight loss therapy without insurance requirements or membership fees. All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and safety. PlexusDx serves all 50 states with flexible commitment options, allowing you to adjust your treatment plan as your needs change.
The optional Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 49 peptides, including your specific GLP1R and FTO genetic variants, to predict your likely responsiveness to semaglutide therapy. This personalized insight helps optimize your starting dose and expected timeline, giving you science-backed weight loss predictions tailored to your unique biology. HSA and FSA accounts are accepted, making treatment more accessible for eligible patients.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight will I lose on semaglutide in the first month?
First-month losses vary widely but typically range from 2-8 pounds as your appetite decreases and you consume fewer calories. Much of this initial loss reflects reduced food intake and fluid shifts rather than pure fat loss. Consistent results emerge by month 2-3 as your body adapts to the medication.
What does the research actually say about semaglutide weight loss?
Major clinical trials (STEP 1-4) demonstrate that patients on 2.4 mg weekly semaglutide lose 14.9-22.3% of starting body weight over 68 weeks, versus 2.4% with placebo. Results are most pronounced between months 4-8, with some variation based on baseline weight, age, and metabolic health.
Can I get compounded semaglutide at PlexusDx, and what does it cost?
PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies starting at $149 per month—your dose may need to go up, but your price won't. No insurance, membership, or prior authorization is required, and treatment is available in all 50 states.
Is semaglutide safe for long-term weight loss, and what side effects should I expect?
Semaglutide is approved for chronic weight management, with most side effects (nausea, constipation, diarrhea) being mild and temporary, typically resolving within 2-4 weeks. Serious side effects are rare but include gallbladder issues and pancreatitis; discuss your full medical history with your prescriber before starting.
How does the PlexusDx Precision Peptide Genetic Test help predict my weight loss results?
The test analyzes your GLP1R, GIPR, FTO, and MC4R genetic variants to predict how effectively your body will respond to semaglutide therapy. Understanding your genetic predispositions helps optimize your starting dose and expected weight loss timeline, making your treatment more personalized and realistic.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When to Take Zepbound: Finding Your Best Time for Sustainable Weight Loss
Does Wegovy Eat Your Muscle? Strategies to Preserve Lean Mass for Sustainable Results